IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
lished 1992. Di vi sions in clude: Contact Lenses;
Lens Care.
Con tacts (Pharm): Chair man: Dor o thy
McDiarmid; Com mer cial Op er a tions: Brian Spiller,
Ron Baroni; Man u fac ture: Da vid Mackay; Gen eral
Con tact: Roueen Miller
Phar ma ceu ti cal Sales: US$ 0-1 mil lion
Prod ucts (% of Sales by Lead ing 5):
95-100%
Ther a peu tic Classes (% of Sales by Lead ing
5): n.a.
Dose Forms (% of Sales by Lead ing 5): n.a.
Prin ci pal Prod ucts:
IN A WINK (ar ti fi cial tears/oc u lar lu bri cant)
AQUIFY (con tact lens prep a ra tion)
AOSEPT (con tact lens prep a ra tion)
PAA (ar ti fi cial tears/oc u lar lu bri cant)
HPMC PAA (ar ti fi cial tears/oc u lar lu bri cant)
Ther a peu tic Range:
ophthalmologicals 100%
Lead ing Dose Forms:
liq uids 76%
gels/sols 24%
HEXAL
Full Name: Hexal Aus tra lia Pty Ltd
Street Ad dress: Level 4, Suite 1-6, 100 Har ris
St, Pyr mont, NSW 2009
Tel: +61 2 9566 1500
Fax: +61 2 9566 1458
Email: askhexal@hexal.com.au
Home Page: www.hexal.com.au
De scrip tion: Man u fac turer, im porter, dis trib u -
tor, sales/detailer. Man u fac tures, dis trib utes,
sells/de tails for other com pa nies. Prod uct ranges
in clude: phar ma ceu ti cal prod ucts (pre scrip tion,
non-pre scrip tion), hos pi tal pharmaceuticals.
Established 1997.
Con tacts (Pharm): Chair man: Clem ens Von
Oswald; Com mer cial Op er a tions: Mike Hobbs;
Gen eral Con tact: Mimi Louie
NOVARTIS
Full Name: Novartis Pharmaceuticals Aus tra lia
Pty Ltd
Postal Ad dress: PO Box 101, North Ryde, NSW
1670
Street Ad dress: 54 Waterloo Rd, North Ryde,
NSW 2113
Tel: +61 2 9805 3555
Fax: +61 2 9805 1330
Home Page: www.novartis.com.au
De scrip tion: Re searcher, im porter, dis trib u tor,
pro moter, sales/detailer. Prod uct ranges in clude:
phar ma ceu ti cal prod ucts (branded, pre scrip tion),
hos pi tal pharmaceuticals, oph thal mic prod ucts.
Es tab lished 1997. 250 phar ma ceu ti cal em ploy ees
in 2008. Di vi sions in clude: On col ogy; Trans plan -
ta tion & Im mu nol ogy; Primary Care;
Ophthalmics.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 51-100 (2008)
Con tacts (Pharm): Chair man: Mar tin Cross;
Com mer cial Op er a tions: Das Nair, Rob ert
Huggan, Roger Suttie, Sa rah Boyce; Mar ket Re -
search: Darren Griffiths, Marion Tan, Ga bri elle
Wil son; Re search & De vel op ment: Dr Nicol
Kurstjens; Gen eral Con tact: Sue Cavanagh
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 390-400 mil lion
Prod ucts (% of Sales by Lead ing 5): 50-55%
Ther a peu tic Classes (% of Sales by Lead ing
5): 55-60%
Dose Forms (% of Sales by Lead ing 5):
80-85%
Prin ci pal Prod ucts:
LUCENTIS (oc u lar antineovascularization prod -
uct)
GLIVEC (antineoplastic other)
FAMVIR (an ti vi ral non-HIV)
NEORAL (immunosuppressive agent)
ZOMETA (bone cal cium reg u la tor)
Ther a peu tic Range:
ophthalmologicals 24%
antineoplastics 15%
immunosuppressive agents 8%
antivirals sys temic 7%
musculoskeletal drugs other 5%
Lead ing Dose Forms:
coated tab lets 30%
vi als 27%
tab lets 15%
cap sules 7%
am poules 5%
NOVARTIS CON SUMER HEALTH
Full Name: Novartis Con sumer Health
Australasia Pty Ltd
Postal Ad dress: PO Box 4499, Mel bourne, Vic to -
ria 3170
Street Ad dress: 327 - 329 Po lice Road, Level 2,
Mul grave, Mel bourne, Vic to ria 3170
Tel: +61 3 9701 2711
Fax: +61 3 9701 2911
© 2009 IMS Health In cor po rated or its af fil i ates Page 149